Business Description
K Pharma Inc
ISIN : JP3280900006
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.01 | |||||
9-Day RSI | 55.6 | |||||
14-Day RSI | 54.65 | |||||
6-1 Month Momentum % | -18.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 18.54 | |||||
Quick Ratio | 18.48 | |||||
Cash Ratio | 18.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | 44.46 | |||||
ROE % | -12.68 | |||||
ROA % | -11.44 | |||||
ROIC % | -470.61 | |||||
ROC (Joel Greenblatt) % | -71621.11 | |||||
ROCE % | -14.04 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.08 | |||||
PB Ratio | 2.34 | |||||
Price-to-Tangible-Book | 2.34 | |||||
Price-to-Free-Cash-Flow | 15.91 | |||||
Price-to-Operating-Cash-Flow | 15.57 | |||||
EV-to-EBIT | -14.06 | |||||
EV-to-EBITDA | -14.06 | |||||
EV-to-Revenue | 4.01 | |||||
EV-to-FCF | 8.91 | |||||
Price-to-Net-Current-Asset-Value | 2.35 | |||||
Price-to-Net-Cash | 2.38 | |||||
Earnings Yield (Greenblatt) % | -7.11 | |||||
FCF Yield % | 6.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
K Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 1,000 | ||
EPS (TTM) (円) | -24.973 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 54.65 | ||
14-Day ATR (円) | 21.328481 | ||
20-Day SMA (円) | 613.1 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (円) | 531 - 980 | ||
Shares Outstanding (Mil) | 11.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
K Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
K Pharma Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
K Pharma Inc Frequently Asked Questions
What is K Pharma Inc(TSE:4896)'s stock price today?
When is next earnings date of K Pharma Inc(TSE:4896)?
Does K Pharma Inc(TSE:4896) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |